<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "../dtd/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRI</journal-id>
<journal-title>Journal of Reproduction and Infertility</journal-title>
<issn pub-type="ppub">2228-5482</issn>
<issn pub-type="epub">2251-676X</issn>
<publisher>
<publisher-name>Avicenna Research Institute</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">JRI-14-190</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Protective Effect of Ethyl Pyruvate on Epididymal Sperm Characteristics, Oxidative Stress and Testosterone Level in Methotrexate Treated Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Atashfaraz</surname>
<given-names>Elham</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Farokhi</surname>
<given-names>Farah</given-names>
</name>
<xref ref-type="aff" rid="AF0002">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Najafi</surname>
<given-names>Gholamreza</given-names>
</name>
<xref ref-type="aff" rid="AF0003">3</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Faculty of Science, Urmia University, Urmia, Iran</aff>
<aff id="AF0002">
<label>2</label>Department of Histology and Embryology, Faculty of Science, Urmia University, Urmia, Iran</aff>
<aff id="AF0003">
<label>3</label>Department of Anatomy and Embryology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>
<italic>Corresponding Author:</italic> Elham Atashfaraz, Student of Histology and Embryology, Faculty of Science, Urmia University, Urmia, Iran. <italic>E-mail:</italic> <email xlink:href="a.farazelham@yahoo.com">a.farazelham@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Oct-Dec</season>
<year>2013</year>
</pub-date>
<volume>14</volume>
<issue>4</issue>
<fpage>190</fpage>
<lpage>196</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>07</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>09</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2013 Avicenna Research Institute</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
<p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</p>
</license>
</permissions> 
<abstract>
<sec id="st1">
<title>Background</title>
<p>Methotrexate (MTX) is an anti-metabolite drug widely used in treatment of neoplastic disorders, rheumatoid arthritis and psoriasis. The ester derivative, ethyl pyruvate (EP) is stable in solution and should function as an antioxidant and energy precursor. This study was conducted to evaluate the protective role of EP on sperm parameters, testosterone level and malondialdehyde (MDA) production in mice treated with MTX.</p>
</sec>
<sec id="st2">
<title>Methods</title>
<p>32 adult male NMRI mice weighing 26&#x00B1;2 <italic>g</italic> were divided into 4 groups. Group 1 received 0.1 <italic>ml/mice/day</italic> of distilled water intraperitoneally for 30 days (<italic>ip</italic>). Group 2 was treated with methotrexate at a dose of 20 <italic>mg/kg</italic> once a week (<italic>ip</italic>) for 30 days. Group 3 was treated with ethyl pyruvate at a dose of 40 <italic>mg/kg/daily</italic> (<italic>ip</italic>) for 30 days. Group 4 was treated with methotrexate (20 <italic>mg/kg</italic>) once a week simultaneously with ethyl pyruvate 40 <italic>mg/kg</italic> for 30 days. The results were analyzed by oneway ANOVA. A p&#x003C;0.05 was considered to be significant.</p>
</sec>
<sec id="st3">
<title>Results</title>
<p>The results showed significant (p&#x003C;0.05) decrease in sperm count and sperm motility as well as testosterone concentration while sperm with damaged DNA and MDA concentration in mice treated with MTX in comparison with control and MX+EP groups increased significantly (p&#x003C;0.05). Instead, MTX+EP group caused partial amelioration in all parameters mentioned above.</p>
</sec>
<sec id="st4">
<title>Conclusion</title>
<p>Based on the present study, it can be concluded that MTX induced toxicity in sperm parameters and serum level of testosterone and increased MDA level. EP with its antioxidant properties could be administrated during treatment with MTX due to its protective effects on sperm parameters, plasma testosterone levels and lipid peroxidation.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Ethyl pyruvate</kwd>
<kwd>Malondialdehyde</kwd>
<kwd>Methotrexate</kwd>
<kwd>Mice</kwd>
<kwd>Spermatozoa</kwd>
<kwd>Testosterone</kwd>
</kwd-group>
</article-meta>
<notes><p><bold>To cite this article:</bold> Atashfaraz E, Farokhi F, Najafi Gh. Protective Effect of Ethyl Pyruvate on Epididymal Sperm Characteristics, Oxidative Stress and Testosterone Level in Methotrexate Treated Mice. J Reprod Infertil. 2013;14(4):190-196.</p></notes>
</front>
<body>
<sec id="S0001" sec-type="intro">
<title>Introduction</title>
<p>In recent years, natural antioxidant products have gained attention based on their protective effects against drug-induced toxicities especially whenever free radical generation is involved (<xref ref-type="bibr" rid="CIT0001">1</xref>). The intake in human diet of antioxidant compounds or compounds that ameliorate or enhance the biological antioxidant mechanisms, can prevent and in some cases help in the treatment of some oxidative-related disorders and organ toxicity events (<xref ref-type="bibr" rid="CIT0002">2</xref>). Pyruvate is a key intermediate metabolite of glucose and a potent antioxidant and free radical scavenger (<xref ref-type="bibr" rid="CIT0003">3</xref>).</p>
<p>Pyruvate has been shown to afford protection in numerous <italic>in vitro</italic> and <italic>in vivo</italic> models including oxidant mediated cellular ones or organ system injury (<xref ref-type="bibr" rid="CIT0004">4</xref>). It is a well-known scavenger of hydrogen peroxide and superoxide radicals (<xref ref-type="bibr" rid="CIT0005">5</xref>, <xref ref-type="bibr" rid="CIT0006">6</xref>). In the presence of hydrogen peroxide, pyruvate will decarboxylate to yield acetate, water and carbon dioxide (<xref ref-type="bibr" rid="CIT0007">7</xref>). Unfortunately, the usefulness of pyruvate as a therapeutic agent is diminished by its very poor stability in solution (<xref ref-type="bibr" rid="CIT0008">8</xref>). Ethyl pyruvate (EP), a simple aliphatic ester derived from pyruvic acid, is safer and more stable than pyruvate (<xref ref-type="bibr" rid="CIT0008">8</xref>). Like pyruvate, ethyl pyruvate could also rapidly and stoichiometrically scavenge hydrogen peroxide. Supporting this idea, some studies show that treatment with EP provides biochemical evidence for a decrease in oxidative stress both <italic>in vitro</italic> and <italic>in vivo</italic> and in models of ischemia/reperfusion injury (<xref ref-type="bibr" rid="CIT0005">5</xref>, <xref ref-type="bibr" rid="CIT0009">9</xref>).</p>
<p>Chemotherapy is one of the most effective methods for the treatment of cancer, but is often associated with several short and long-term toxicities (<xref ref-type="bibr" rid="CIT0010">10</xref>). MTX is a widely used anti-cancer drug and a well-known immunosuppressant introduced for therapeutic application in 1950 (<xref ref-type="bibr" rid="CIT0011">11</xref>). It is used against a broad range of neoplastic disorders including acute lymphoblastic leukaemia, non-Hodgkin&#x0027;s lymphoma, breast cancer and testicular tumours (<xref ref-type="bibr" rid="CIT0012">12</xref>, <xref ref-type="bibr" rid="CIT0013">13</xref>). Further, it is effective for the treatment of psoriasis, rheumatoid arthritis and different immunesuppressive propose (<xref ref-type="bibr" rid="CIT0014">14</xref>, <xref ref-type="bibr" rid="CIT0015">15</xref>).</p>
<p>The basic principle of its therapeutic efficacy is related to the inhibition of dihydrofolate reductase, a key enzyme in the folic acid metabolism, which converts dihydrofolicacid to tetrahydrofolic acid. The perturbation in the folic acid metabolism leads to depletion of nucleotide precursors like thymidylates and purines, which in turn inhibits DNA, RNA and protein synthesis (<xref ref-type="bibr" rid="CIT0016">16</xref>, <xref ref-type="bibr" rid="CIT0017">17</xref>). MTX has narrow therapeutic index and its toxicity has been reported in various organ systems including gastrointestinal, hematologic and central nervous system. Methotrexate may have an effect on hypothalamic-pituitary-gonadal axis or a direct toxic effect on the gonads (<xref ref-type="bibr" rid="CIT0018">18</xref>). Studies in animals have shown altered spermatogenesis, cytotoxicity and degeneration of spermatocytes, Sertoli cells, and Leydig cells (<xref ref-type="bibr" rid="CIT0019">19</xref>, <xref ref-type="bibr" rid="CIT0020">20</xref>).</p>
</sec>
<sec id="S0002" sec-type="methods">
<title>Methods</title>
<sec id="S20003">
<title>Animals</title>
<p>Thirty two adult male NMRI mice (8-10 weeks old) weighing 26&#x00B1;2 <italic>g</italic> were purchased from animal house of faculty of science Urmia University. All animals were kept under controlled environmental conditions at room temperature (22&#x00B1;2<italic>&#x00B0;C</italic>) with humidity of 50&#x00B1;10% and a 12/12 <italic>hr</italic> photoperiod. The animals were provided with standard diet pellets and water ad libitum.</p>
</sec>
<sec id="S20004">
<title>Experimental design</title>
<p>Animals were randomly divided into four groups, containing 8 mice in each group. Group 1 (control) received distilled water 0.1 <italic>ml/mice/day</italic> (<italic>ip</italic>) for 30 day. Group 2 (MTX) received methotrexate at a dose of 20 <italic>mg/kg</italic> once a week (<italic>ip</italic>) for 30 days. Group 3 (EP) received ethyl pyruvate at a dose of 40 <italic>mg/kg/daily</italic> (<italic>ip</italic>) for 30 days. Group 4 (MTX+EP) received methotrexate at a dose of 20 <italic>mg/kg</italic> once a week (<italic>ip</italic>) concomitant with ethyl pyruvate administration at a dose of 40 <italic>mg/kg</italic> over a week.</p>
</sec>
<sec id="S20005">
<title>Sperm collection</title>
<p>24 <italic>hr</italic> after the end of the treatment period, animals were sacrificed by dislocation of cervical vertebrae. The caudal epididymis was removed after sacrificing the animals and placed into 1 <italic>ml</italic> of HTF medium with 4 <italic>mg/ml</italic> of Bovine Serum Albumin, then minced into small pieces to allow the sperm to swim out and incubated at 37<italic>&#x00B0;C</italic>/5% Co<sub>2</sub> for 30 <italic>min</italic>.</p>
</sec>
<sec id="S20006">
<title>Sperm count</title>
<p>The obtained sperm suspension was centrifuged at 1000 <italic>rpm</italic> for 5 <italic>min</italic>. After centrifugation, 10 <italic>&#x00B5;l</italic> of the supernatant was taken and the epididymal sperm count was determined using Neubauerhemocytometer (<xref ref-type="bibr" rid="CIT0021">21</xref>).</p>
</sec>
<sec id="S20007">
<title>Sperm viability</title>
<p>Sperm viability was evaluated as follows. 20 <italic>&#x00B5;l</italic> of 0.05% Eosin Y -Nigrosin were added into an equal volume of sperm suspension. After 2 <italic>min</italic> of incubation at room temperature, slides were viewed by light microscope with magnification of &#x00D7;400. Dead sperm appeared to be pink and live sperm were not stained. In each sample, 400 sperm were counted and viability percentages were calculated (<xref ref-type="bibr" rid="CIT0022">22</xref>).</p>
</sec>
<sec id="S20008">
<title>Sperm motility</title>
<p>The motility was determined by placing 10 <italic>&#x00B5;l</italic> of the sperm suspersion on a clean pre-warmed microscopic slide, covered with a cover-slip and examined using a light microscope at 400&#x00D7; magnification (Nikon Labophot 2) equipped with a heated stage (37<italic>&#x00B0;C</italic>). The motility of each spermatozoon was graded as &#x201C;RPFM&#x201D; (rapid progressive forward movement), &#x201C;SPFM&#x201D; (slowly progressive forward movement) &#x201C;RM&#x201D; (residual motion) and &#x201C;ML&#x201D; (motionless) and percentages of motile and immotile sperm were obtained (<xref ref-type="bibr" rid="CIT0023">23</xref>).</p>
</sec>
<sec id="S20009">
<title>Acridine Orange (AO) staining</title>
<p>Sperm DNA fragmentation has now become a new biomarker for male infertility diagnosis (<xref ref-type="bibr" rid="CIT0024">24</xref>). Acridine Orange (AO) staining is used, after challenge at a low pH, to distinguish between denatured, single stranded, native, and double-stranded DNA regions in sperm chromatin (<xref ref-type="bibr" rid="CIT0025">25</xref>). The results showed the cytogram patterns of the fluorescence intensity of denatured DNA (red) and native DNA (green). Thick smears were placed in Carnoy&#x0027;s fixative (methanol/ acetic acid 1:3) for 2 <italic>hr</italic> for fixation (<xref ref-type="bibr" rid="CIT0026">26</xref>). The slides were removed from the fixative and allowed to dry for a few minutes. After 5 <italic>min</italic> at laboratory temperature, the sperm were stained with stock solution consisting of 1 <italic>mg</italic> of AO in 1000 <italic>ml</italic> of distilled water and stored in the dark at 4<italic>&#x00B0;C</italic>. The staining solution was prepared as follows. 10 <italic>ml</italic> of the stock solution was added to 40 <italic>ml</italic> of 0.1 <italic>M</italic> citric acid and 2.5 <italic>ml</italic> of 0.3 <italic>M</italic> Na<sub>2</sub>HPO<sub>4</sub> &#x00B7; 7H<sub>2</sub>O (<xref ref-type="bibr" rid="CIT0028">28</xref>). After staining for 5 <italic>min</italic>, the slides were rinsed with deionized water. The sperm were analyzed by fluorescent light microscopy. Red and green sperm could be observed, green sperm were classified as normal DNA and yellow to red sperm were classified as damaged DNA (<xref ref-type="bibr" rid="CIT0026">26</xref>).</p>
</sec>
<sec id="S20010">
<title>Acidic Aniline Blue Staining (AABS)</title>
<p>During histone replacement with protamines and chromatin condensation in spermatogenesis, normal sperm do not stain with aniline blue, but sperm with defective density or immature sperm absorb the stain (<xref ref-type="bibr" rid="CIT0028">28</xref>). Sperm samples were air-dried and fixed for 30 <italic>min</italic> in 3% glutaraldehyde in phosphate buffered saline (pH=7.2). Each smear was stained with 5% acidic aniline blue stain (5 <italic>g</italic> aniline blue (Sigma-Aldrich, USA), 4% acetic acid in double distilled water, pH=3.5 for 5 <italic>min</italic>). At least 200 spermatozoa under light microscopy (Olympus Co, Tokyo, Japan) were counted in each slide (<xref ref-type="bibr" rid="CIT0029">29</xref>).</p>
</sec>
<sec id="S20011">
<title>Measurement of Malondialdehyde (MDA)</title>
<p>In order to do this, 300 <italic>&#x00B5;l</italic> of 10% trichloroacetic acid was added to 150 <italic>&#x00B5;l</italic> of the sample and centrifuged at 1,000 <italic>rpm</italic> for 10 <italic>min</italic> at 4<italic>&#x00B0;C</italic>. 300 <italic>&#x00B5;l</italic> of supernatant was transferred to a test tube with 300 <italic>&#x00B5;l</italic> of 67% thiobarbituric acid and incubated at 100<italic>&#x00B0;C</italic> for 25 <italic>min</italic>. 5 <italic>min</italic> after cooling the solution, a pink color appeared because of MDA-TBA reaction and was evaluated using a spectrophotometer at a wavelength of 535 <italic>nm</italic> (<xref ref-type="bibr" rid="CIT0030">30</xref>).</p>
</sec>
<sec id="S20012">
<title>Testosterone assay</title>
<p>After collecting blood, samples were centrifuged to isolate serum and kept at &#x2212;80<italic>&#x00B0;C</italic> until biochemical analysis with immuneradiometric technique (WHO/Sigma Asso-RTGC-768/98) for testosterone measurement.</p>
</sec>
<sec id="S20013">
<title>Statistical analysis</title>
<p>Results were shown as mean&#x00B1; standard error of mean (S.E.M.) for each group. For comparison between the groups, the results were analyzed by SPSS 16 software, using oneway ANOVA followed by a Bonferroni post hoc test. A p&#x003C;0.05 was considered significant.</p>
</sec>
</sec>
<sec id="S0014" sec-type="results">
<title>Results</title>
<sec id="S20015">
<title>Sperm parameters</title>
<p>The results revealed that sperm count decreased significantly (p&#x003C;0.05) in methotrexate group in comparison with the control group. Ethyl pyruvate+methotrexate group revealed significant enhancement (p&#x003C;0.05) in sperm count which are presented in <xref ref-type="table" rid="T0001">Table 1</xref>. There was no significant (p&#x003E;0.05) difference in sperm maturity among groups. Treatment with anti-neoplastic drug (MTX) caused a significant decrease in viability and an increase in sperm with damaged DNA compared with the control group while Ethyl pyruvate caused improvement in viability and DNA fragmentation in MTX+EP group (<xref ref-type="fig" rid="F0001">Figures 1</xref>, <xref ref-type="fig" rid="F0002">2</xref>, <xref ref-type="fig" rid="F0003">3</xref>; <xref ref-type="table" rid="T0001">Table 1</xref>).</p>
<fig id="F0001">
<label>Figure 1</label>
<caption>
<p>MTX+EP group, live sperm; 1: with uncoloured head and dead sperm; 2: with red head (Eosin Y Nigrosin &#x00D7;1000)</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JRI-14-190-g001.tif" alt-version="no"/>
</fig>
<fig id="F0002">
<label>Figure 2</label>
<caption>
<p>EP group: sperm head with mature nuclei is light blue; 1: and sperm head containing immature nuclear chromatin is dark blue; 2: (Aniline blue &#x00D7;1000)</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JRI-14-190-g002.tif" alt-version="no"/>
</fig>
<fig id="F0003">
<label>Figure 3</label>
<caption>
<p>MTX+EP group: sperm with normal DNA integrity had green fluorescence, and those with diminished DNA integrity had orange-red staining (Acridine orange &#x00D7;400)</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JRI-14-190-g003.tif" alt-version="no"/>
</fig>
<table-wrap id="T0001">
<label>Table 1</label>
<caption>
<p>The effect of methotrexate and Ethyl pyruvate on wperm count, sperm viability, sperm maturity and DNA damage in mice (M&#x00B1;SE)</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">Group</th>
<th align="center">Sperm count (&#x00D7;10<sup>6</sup>)</th>
<th align="center">Sperm viability (<italic>%</italic>)</th>
<th align="center">Sperm maturity (<italic>%</italic>)</th>
<th align="center">Acridine orange+(<italic>%</italic>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">
<bold>Control</bold>
</td>
<td align="center">26.66&#x00B1;1.87</td>
<td align="center">88.00&#x00B1;2.88</td>
<td align="center">89.00&#x00B1;0.57</td>
<td align="center">5.73&#x00B1;0.29</td>
</tr>
<tr>
<td align="left">
<bold>MTX</bold>
</td>
<td align="center">7.50&#x00B1; 1.15 <xref ref-type="table-fn" rid="TF0001">a</xref>
</td>
<td align="center">52.33&#x00B1;2.33 <xref ref-type="table-fn" rid="TF0001">a</xref>
</td>
<td align="center">90.33&#x00B1;1.76</td>
<td align="center">12.66&#x00B1;1.4 <xref ref-type="table-fn" rid="TF0001">a</xref>
</td>
</tr>
<tr>
<td align="left">
<bold>EP</bold>
</td>
<td align="center">25.94&#x00B1;0.81 <xref ref-type="table-fn" rid="TF0002">b</xref>
</td>
<td align="center">81.66&#x00B1;2.33 <xref ref-type="table-fn" rid="TF0001">a</xref><xref ref-type="table-fn" rid="TF0002">b</xref>
</td>
<td align="center">90.33&#x00B1;0.33</td>
<td align="center">6.26&#x00B1;0.52 <xref ref-type="table-fn" rid="TF0002">b</xref>
</td>
</tr>
<tr>
<td align="left">
<bold>MTX+EP</bold>
</td>
<td align="center">15.16&#x00B1;1.74 <xref ref-type="table-fn" rid="TF0001">a</xref><xref ref-type="table-fn" rid="TF0002">b</xref>
</td>
<td align="center">63.88&#x00B1;4.13 <xref ref-type="table-fn" rid="TF0001">a</xref><xref ref-type="table-fn" rid="TF0002">b</xref>
</td>
<td align="center">96.00&#x00B1;1.15</td>
<td align="center">7.00&#x00B1;0.75 <xref ref-type="table-fn" rid="TF0002">b</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF0001">
<label>a</label>
<p>Different significant (p&#x003C;0.05) compared with control group</p>
</fn>
<fn id="TF0002">
<label>b</label>
<p>Different significant (p&#x003C;0.05) compared with MTX group</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In <xref ref-type="table" rid="T0002">Table 2</xref>, we can see that regarding sperm motility, compared with the control group, RPFM decreased significantly (p&#x003C;0.05) in methotrexate group. However, Ethyl pyruvate caused an increase in RPFM in MTX+EP group which was significantly (p&#x003C;0.05) higher compared with the MTX group. SPFM results indicated that the difference between groups was not significant. RM and ML in MTX treatment group increased significantly (p&#x003C;0.05). MTX treatment in EP supplemented animals showed a significant reduction (p&#x003C;0.05) in RM and ML compared with MTX group alone (<xref ref-type="table" rid="T0002">Table 2</xref>).</p>
<table-wrap id="T0002">
<label>Table 2</label>
<caption>
<p>Effect of EP on sperm motility in mice treated with MTX (M&#x00B1;SE)</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">Group</th>
<th align="center">Sperm motility (RPFM) (<italic>%</italic>)</th>
<th align="center">Sperm motility (SPFM) (<italic>%</italic>)</th>
<th align="center">Sperm motility (RM) (<italic>%</italic>)</th>
<th align="center">Sperm motility (ML) (<italic>%</italic>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">
<bold>Control</bold>
</td>
<td align="center">66.12&#x00B1;0.54</td>
<td align="center">14.28&#x00B1;1.00</td>
<td align="center">12.10&#x00B1;1.76</td>
<td align="center">11.51&#x00B1;1.61</td>
</tr>
<tr>
<td align="left">
<bold>MTX</bold>
</td>
<td align="center">26.10&#x00B1;1.82 <xref ref-type="table-fn" rid="TF0003">a</xref></td>
<td align="center">13.73&#x00B1;1.89</td>
<td align="center">39.57&#x00B1;2.60 <xref ref-type="table-fn" rid="TF0003">a</xref>
</td>
<td align="center">20.59&#x00B1;0.68 <xref ref-type="table-fn" rid="TF0003">a</xref>
</td>
</tr>
<tr>
<td align="left">
<bold>EP</bold>
</td>
<td align="center">61.30&#x00B1;2.13 <xref ref-type="table-fn" rid="TF0004">b</xref>
</td>
<td align="center">13.53&#x00B1;.37</td>
<td align="center">17.23&#x00B1;3.51 <xref ref-type="table-fn" rid="TF0004">b</xref>
</td>
<td align="center">7.93&#x00B1;1.30 <xref ref-type="table-fn" rid="TF0004">b</xref>
</td>
</tr>
<tr>
<td align="left">
<bold>MTX+EP</bold>
</td>
<td align="center">49.35&#x00B1;2.92 <xref ref-type="table-fn" rid="TF0003">a</xref><xref ref-type="table-fn" rid="TF0004">b</xref>
</td>
<td align="center">16.80&#x00B1;1.10</td>
<td align="center">21.58&#x00B1;1.31<xref ref-type="table-fn" rid="TF0003">a</xref><xref ref-type="table-fn" rid="TF0004">b</xref>
</td>
<td align="center">11.83&#x00B1;1.24 <xref ref-type="table-fn" rid="TF0004">b</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF0003">
<label>a</label>
<p>Different significant (p&#x003C;0.05) compared with control group</p>
</fn>
<fn id="TF0004">
<label>b</label>
<p>Different significant (p&#x003C;0.05) compared with MTX group</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S20016">
<title>Biochemical results</title>
<p>The results of biochemical analyses were shown in <xref ref-type="table" rid="T0003">Table 3</xref>. Briefly, the level of MDA, a major degradation product of lipid peroxidation, was significantly increased in MTX treated mice compared with the control group (p&#x003C;0.05). There was a significant restoration in MDA level in the groups that received EP treatment with MTX (p&#x003C;0.05).</p>
<table-wrap id="T0003">
<label>Table 3</label>
<caption>
<p>Comparison of the effect of EP on testosterone level and lipid peroxidation caused by MTX (M&#x00B1;SE)</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">Group</th>
<th align="center">MDA (<italic>&#x00B5;mol/gr</italic> tissue)</th>
<th align="center">Testosterone (<italic>ng/ml</italic>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">
<bold>control</bold>
</td>
<td align="center">165.66&#x00B1;4.63</td>
<td align="center">0.42&#x00B1;0.02</td>
</tr>
<tr>
<td align="left">
<bold>MTX</bold>
</td>
<td align="center">357.33&#x00B1;4.09 <xref ref-type="table-fn" rid="TF0005">a</xref>
</td>
<td align="center">0.19&#x00B1;0.02 <xref ref-type="table-fn" rid="TF0005">a</xref>
</td>
</tr>
<tr>
<td align="left">
<bold>EP</bold>
</td>
<td align="center">187.00&#x00B1;9.53 <xref ref-type="table-fn" rid="TF0005">a</xref><xref ref-type="table-fn" rid="TF0006">b</xref>
</td>
<td align="center">0.58&#x00B1;0.02 <xref ref-type="table-fn" rid="TF0005">a</xref><xref ref-type="table-fn" rid="TF0006">b</xref>
</td>
</tr>
<tr>
<td align="left">
<bold>MTX+EP</bold>
</td>
<td align="center">203.66&#x00B1;20.4 <xref ref-type="table-fn" rid="TF0005">a</xref><xref ref-type="table-fn" rid="TF0006">b</xref>
</td>
<td align="center">0.49&#x00B1;0.04 <xref ref-type="table-fn" rid="TF0006">b</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF0005">
<label>a</label>
<p>Different significant (p&#x003C;0.05) compared with control group</p>
</fn>
<fn id="TF0006">
<label>b</label>
<p>Different significant (p&#x003C;0.05) compared with MTX group</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The level of testosterone was found to be significantly lower in MTX-treated group when compared with other groups (p&#x003C;0.005). Ethyl pyruvate administration, after MTX, caused significant increase in testosterone concentrations when compared with MTX and control group alone (p&#x003C; 0.05). On the other hand, EP+MTX group testosterone level was similar to the control group.</p>
</sec>
</sec>
<sec id="S0017" sec-type="discussion">
<title>Discussion</title>
<p>Although most of chemotherapeutic agents are mutagenic and carcinogenic (<xref ref-type="bibr" rid="CIT0031">31</xref>), they are extensively used for the treatment of various types of cancers, as at times, they cure the disease or at least increase the life expectancy of cancer patients (<xref ref-type="bibr" rid="CIT0032">32</xref>).</p>
<p>Also, research shows that there is a significant relationship between ROS production and apoptosis which cause DNA damage in sperm. We reached the same results in our AO assays, observing that MTX caused a significant increase in DNA fragmentation (p&#x003C;0.05).</p>
<p>Sperm counts are a crude measure of fertility (<xref ref-type="bibr" rid="CIT0033">33</xref>, <xref ref-type="bibr" rid="CIT0034">34</xref>). In this study, we observed that sperm count and viability were reduced significantly in MTX-treated animals. Decrease in sperm count often results due to the interference in the spermatogenesis process and the elimination of sperm cells at different stages of development (<xref ref-type="bibr" rid="CIT0034">34</xref>, <xref ref-type="bibr" rid="CIT0035">35</xref>).</p>
<p>Sperm motility is also as important as the counts in respect to male fertility. We found that MTX -treated mice had less sperm motility. The significant reduction in sperm motility may be due to the status of oxidative stress observed during MTX administration which is accompanied by increased lipid peroxidation in various tissues (<xref ref-type="bibr" rid="CIT0036">36</xref>, <xref ref-type="bibr" rid="CIT0037">37</xref>). Lipid peroxidation products in testis were determined by measuring malondialdehyde (MDA). Malondialdehyde is a good indicator of the degree of lipid peroxidation, which in our study, the level of MDA in MTX-treated rats was significantly higher than the control group (p&#x003C;0.05). This finding was in agreement with several reports demonstrating MTX-induced oxidative stress in tissues (<xref ref-type="bibr" rid="CIT0038">38</xref>, <xref ref-type="bibr" rid="CIT0039">39</xref>).</p>
<p>Whereas EP has been shown to inhibit lipid peroxidation, it is a marker for oxidative stress both in <italic>in vitro</italic> (<xref ref-type="bibr" rid="CIT0040">40</xref>) and <italic>in vivo</italic> (<xref ref-type="bibr" rid="CIT0041">41</xref>) conditions. Tsung et al. have recently shown that EP decreases hepatic lipid peroxidation (<xref ref-type="bibr" rid="CIT0042">42</xref>). Interestingly, in our combined EP-MTX treated groups, we observed that MDA value was significantly lower than that of MTX-treated group. Our results in MDA measurement are in agreement with previous studies (<xref ref-type="bibr" rid="CIT0041">41</xref>, <xref ref-type="bibr" rid="CIT0043">43</xref>).</p>
<p>Recent advances showed that ROS and hydrogen peroxides are linked with the development of several pathological processes associated with chemotherapy, including adverse effects of anti-tumor drugs. It may be suggested that the cells could be more sensitive to ROS, which subsequently results in reduction of effectiveness of the antioxidant enzyme defense system (<xref ref-type="bibr" rid="CIT0044">44</xref>, <xref ref-type="bibr" rid="CIT0045">45</xref>).</p>
<p>On the other hand, EP is unlikely to be harmful to humans, given its close similarity to an endogenous metabolite, its safety profiles in animals, and its common use as a food supplement. EP can react with ROS both via oxidative carboxylation and via formation of hydroxylated adducts at the 3-carbon (<xref ref-type="bibr" rid="CIT0046">46</xref>).</p>
<p>In the present study, EP was administered in the form of antioxidant and by a dose of 40 <italic>mg/kg</italic> which because of its antioxidant and free radical scavenging properties could reduce the side effects of MTX such as DNA damage, low sperm count and decreased viability and motility of sperm in MTX treated mice.</p>
</sec>
<sec id="S0018" sec-type="conclusion">
<title>Conclusion</title>
<p>This study clearly showed that MTX treatment in mice induced testicular injury as is evident from the decreased count, viability, motility of sperm and sperm DNA damage. Treatment with EP significantly ameliorated the toxic side effects of MTX. Thus, the results of the present study encourage new experimental and clinical studies to evaluate the efficacy of EP as an adjunctive agent to ameliorate the toxic effects of anti-neoplastic drugs that cause oxidative tissue injury.</p>
</sec> 
</body>
<back>
<ack>
<title>Acknowledgement</title>
<p>The authors would like to thank Mr. Eskandar Poorgadim for technical assistance and laboratory equipment supply.</p>
</ack>
<sec id="S0019">
<title>Conflict of Interest</title>
<p>There was no conflict of interest between authors.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="CIT0001">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frei</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Higdon</surname>
<given-names>JV</given-names>
</name>
</person-group>
<article-title>Antioxidant activity of tea polyphenols in vivo: evidence from animal studies</article-title>
<source>J Nutr.</source>
<year>2003</year>
<volume>133</volume>
<issue>10</issue>
<fpage>3275S</fpage>
<lpage>84</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0002">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Havsteen</surname>
<given-names>BH</given-names>
</name>
</person-group>
<article-title>The biochemistry and medical significance of the flavonoids</article-title>
<source>Pharmacol Ther.</source>
<year>2002</year>
<volume>96</volume>
<issue>2-3</issue>
<fpage>67</fpage>
<lpage>202</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0003">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varma</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Hegde</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Kovtun</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Oxidative damage to lens in culture: reversibility by pyruvate and ethyl pyruvate</article-title>
<source>Ophthalmologica.</source>
<year>2006</year>
<volume>220</volume>
<issue>1</issue>
<fpage>52</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0004">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x0027;Donnell-Tormey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nathan</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Lanks</surname>
<given-names>K</given-names>
</name>
<name>
<surname>DeBoer</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>de la Harpe</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Secretion of pyruvate. An antioxidant defense of mammalian cells</article-title>
<source>J Exp Med.</source>
<year>1987</year>
<volume>165</volume>
<issue>2</issue>
<fpage>500</fpage>
<lpage>14</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0005">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varma</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Devamanoharan</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Prevention of intracellular oxidative stress to lens by pyruvate and its ester</article-title>
<source>Free Radic Res.</source>
<year>1998</year>
<volume>28</volume>
<issue>2</issue>
<fpage>131</fpage>
<lpage>5</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0006">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olek</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Antosiewicz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Popinigis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gabbianelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fedeli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Falcioni</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Pyruvate but not lactate prevents NADH-induced myoglobin oxidation</article-title>
<source>Free Radic Biol Med.</source>
<year>2005</year>
<volume>38</volume>
<issue>11</issue>
<fpage>1484</fpage>
<lpage>90</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0007">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Constantopoulos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Barranger</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Nonenzymatic decarboxylation of pyruvate</article-title>
<source>Anal Biochem.</source>
<year>1984</year>
<volume>139</volume>
<issue>2</issue>
<fpage>353</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0008">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sims</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Wattanasirichaigoon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Menconi</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Ajami</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Ringer&#x0027;s ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats</article-title>
<source>Crit Care Med.</source>
<year>2001</year>
<volume>29</volume>
<issue>8</issue>
<fpage>1513</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0009">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devamanoharan</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Henein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Varma</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>Attenuation of sugar cataract by ethyl pyruvate</article-title>
<source>Mol Cell Biochem.</source>
<year>1999</year>
<volume>200</volume>
<issue>1-2</issue>
<fpage>103</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0010">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meirow</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lewis-Roness</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ornoy</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Genetic and teratogenic effects of cancer treatments on gametes and embryos</article-title>
<source>Hum Reprod Update.</source>
<year>2001</year>
<volume>7</volume>
<issue>4</issue>
<fpage>394</fpage>
<lpage>403</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0011">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>van der Wilt</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>van Moorsel</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Kroep</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Bergman</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ackland</surname>
<given-names>SP</given-names>
</name>
</person-group>
<article-title>Basis for effective combination cancer chemotherapy with antimetabolites</article-title>
<source>Pharmacol Ther.</source>
<year>2000</year>
<volume>87</volume>
<issue>2-3</issue>
<fpage>227</fpage>
<lpage>53</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0012">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhury</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Palo</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Cytogenetic toxicity of methotrexate in mouse bone marrow</article-title>
<source>Environ Toxicol Pharmacol.</source>
<year>2000</year>
<volume>8</volume>
<issue>3</issue>
<fpage>191</fpage>
<lpage>196</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0013">
<label>13</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Mouridsen</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Reibel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nauntofte</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction</article-title>
<source>Oral Oncol.</source>
<year>2008</year>
<volume>44</volume>
<issue>2</issue>
<fpage>162</fpage>
<lpage>73</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0014">
<label>14</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chow</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Random population-wide genetic damage induced in replicating cells treated with methotrexate</article-title>
<source>Mutat Res.</source>
<year>1998</year>
<volume>413</volume>
<issue>3</issue>
<fpage>251</fpage>
<lpage>64</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0015">
<label>15</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gisondi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Girolomoni</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Biologic therapies in psoriasis: a new therapeutic approach</article-title>
<source>Autoimmun Rev.</source>
<year>2007</year>
<volume>6</volume>
<issue>8</issue>
<fpage>515</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0016">
<label>16</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novakovic</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dordevic</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Grujicic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Marinkovic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jankovic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arsenijevic</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Effect of intratumoral application of methotrexate in vivo on frequency of micronuclei in peripheral blood lymphocytes</article-title>
<source>Arch Oncol.</source>
<year>2003</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>4</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0017">
<label>17</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cronstein</surname>
<given-names>BN</given-names>
</name>
</person-group>
<article-title>Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis</article-title>
<source>Bull NYU Hosp Jt Dis.</source>
<year>2007</year>
<volume>65</volume>
<issue>3</issue>
<fpage>168</fpage>
<lpage>73</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0018">
<label>18</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Padmanabhan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Vikram</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ramarao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jena</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid</article-title>
<source>Mutat Res.</source>
<year>2009</year>
<volume>673</volume>
<issue>1</issue>
<fpage>43</fpage>
<lpage>52</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0019">
<label>19</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saxena</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Dhungel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jha</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Effect of chronic low dose of methotrexate on cellular proliferation during spermatogenesis in rats</article-title>
<source>Arch Androl.</source>
<year>2004</year>
<volume>50</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>5</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0020">
<label>20</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shrestha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dhungel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maskey</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Effect of methotrexate (MTX) administration on spermatogenesis: an experimental on animal model</article-title>
<source>Nepal Med Coll J.</source>
<year>2007</year>
<volume>9</volume>
<issue>4</issue>
<fpage>230</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0021">
<label>21</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Padmanabhan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Vikram</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ramarao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jena</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Cytotoxic and genotoxic effects of methotrexate in germ cells of male Swiss mice</article-title>
<source>Mutat Res</source>
<year>2008</year>
<volume>655</volume>
<issue>1-2</issue>
<fpage>59</fpage>
<lpage>67</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0022">
<label>22</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wyrobek</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Burkhart</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Kapp</surname>
<given-names>RW</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Letz</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals. A report of the U.S. Environmental Protection Agency Gene-Tox Program</article-title>
<source>Mutat Res.</source>
<year>1983</year>
<volume>115</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>72</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0023">
<label>23</label>
<nlm-citation citation-type="confproc">
<collab>World Health Organization</collab>
<article-title>WHO Laboratory manual for the examination of human semen and sperm &#x2013; cervical mucus interaction</article-title>
<year>1992</year>
<edition>3rd ed</edition>
<publisher-loc>Cambridge</publisher-loc>
<publisher-name>Cambridge University press</publisher-name>
</nlm-citation>
</ref> 
<ref id="CIT0024">
<label>24</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrell</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Emery</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Hammoud</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Altered protamine expression and diminished spermatogenesis: what is the link?</article-title>
<source>Hum Reprod Update.</source>
<year>2007</year>
<volume>13</volume>
<issue>3</issue>
<fpage>313</fpage>
<lpage>27</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0025">
<label>25</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bungum</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Humaidan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Spano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jepson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bungum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Giwercman</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI</article-title>
<source>Hum Reprod.</source>
<year>2004</year>
<volume>19</volume>
<issue>6</issue>
<fpage>1401</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0026">
<label>26</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanfar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sadrkhanlou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ahmadi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shojaei-Sadee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rezvanfar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mohammadirad</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Protection of cyclophosphamide-induced toxicity in reproductive tract histology, sperm characteristics, and DNA damage by an herbal source; evidence for role of free-radical toxic stress</article-title>
<source>Hum Exp Toxicol.</source>
<year>2008</year>
<volume>27</volume>
<issue>12</issue>
<fpage>901</fpage>
<lpage>10</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0027">
<label>27</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erenpreiss</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bars</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lipatnikova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Erenpreisa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zalkalns</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Comparative study of cytochemical tests for sperm chromatin integrity</article-title>
<source>J Androl.</source>
<year>2001</year>
<volume>22</volume>
<issue>1</issue>
<fpage>45</fpage>
<lpage>53</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0028">
<label>28</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meistrich</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Brock</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Grimes</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Platz</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Hnilica</surname>
<given-names>LS</given-names>
</name>
</person-group>
<article-title>Nuclear protein transitions during spermatogenesis</article-title>
<source>Fed Proc.</source>
<year>1978</year>
<volume>37</volume>
<issue>11</issue>
<fpage>2522</fpage>
<lpage>5</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0029">
<label>29</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talebi</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Moein</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Tabibnejad</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ghasemzadeh</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Effect of varicocele on chromatin condensation and DNA integrity of ejaculated spermatozoa using cytochemical tests</article-title>
<source>Andrologia.</source>
<year>2008</year>
<volume>40</volume>
<issue>4</issue>
<fpage>245</fpage>
<lpage>51</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0030">
<label>30</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hosseinzadeh</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sadeghnia</surname>
<given-names>HR</given-names>
</name>
</person-group>
<article-title>Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus</article-title>
<source>J Pharm Pharm Sci.</source>
<year>2005</year>
<volume>8</volume>
<issue>3</issue>
<fpage>394</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0031">
<label>31</label>
<nlm-citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Anders</surname> 
<given-names>MW</given-names>
</name>
<name>
<surname>Bull</surname> 
<given-names>RJ</given-names>
</name>
<name>
<surname>Cantor</surname> 
<given-names>KP</given-names>
</name>
<name>
<surname>Chakraborti</surname> 
<given-names>D</given-names>
</name>
<name>
<surname>Chen</surname> 
<given-names>CJ</given-names>
</name>
<name>
<surname>DeAngelo</surname> 
<given-names>AB</given-names>
</name>
<etal/>
</person-group>
<article-title>Monographs on the evaluation of carcinogenic risks to humans: pharmaceutical drugs</article-title>
<year>1990</year>
<publisher-loc>Lyon, France</publisher-loc>
<publisher-name>IARC Scientific Publication</publisher-name>
<fpage>415</fpage>
</nlm-citation>
</ref> 
<ref id="CIT0032">
<label>32</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhury</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Palo</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Cytogenetic toxicity of methotrexate in mouse bone marrow</article-title>
<source>Environ Toxicol Pharmacol.</source>
<year>2000</year>
<volume>8</volume>
<issue>3</issue>
<fpage>191</fpage>
<lpage>196</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0033">
<label>33</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Padmanabhan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Vikram</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ramarao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jena</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Cytotoxic and genotoxic effects of methotrexate in germ cells of male Swiss mice</article-title>
<source>Mutat Res.</source>
<year>2008</year>
<volume>655</volume>
<issue>1-2</issue>
<fpage>59</fpage>
<lpage>67</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0034">
<label>34</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel Aziz</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Shouman</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Attia</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Saad</surname>
<given-names>SF</given-names>
</name>
</person-group>
<article-title>A study on the reproductive toxicity of erythrosine in male mice</article-title>
<source>Pharmacol Res.</source>
<year>1997</year>
<volume>35</volume>
<issue>5</issue>
<fpage>457</fpage>
<lpage>62</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0035">
<label>35</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schimenti</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Hanneman</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Schimenti</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Evidence for cyclophosphamide-induced gene conversion and mutation in mouse germ cells</article-title>
<source>Toxicol Appl Pharmacol.</source>
<year>1997</year>
<volume>147</volume>
<issue>2</issue>
<fpage>343</fpage>
<lpage>50</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0036">
<label>36</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabassum</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Parvez</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dev Banerjee</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Siemen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Raisuddin</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice</article-title>
<source>Hum Exp Toxicol.</source>
<year>2007</year>
<volume>26</volume>
<issue>6</issue>
<fpage>509</fpage>
<lpage>18</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0037">
<label>37</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jahovic</surname> 
<given-names>N</given-names>
</name>
<name>
<surname>Cevik</surname> 
<given-names>H</given-names>
</name>
<name>
<surname>Sehirli</surname> 
<given-names>AO</given-names>
</name>
<name>
<surname>Yegen</surname> 
<given-names>BC</given-names>
</name>
<name>
<surname>Sener</surname> 
<given-names>G</given-names>
</name>
</person-group>
<article-title>Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats</article-title>
<source>J Pineal Res.</source>
<year>2003</year>
<volume>34</volume>
<issue>4</issue>
<fpage>282</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0038">
<label>38</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jahovic</surname> 
<given-names>N</given-names>
</name>
<name>
<surname>Sener</surname> 
<given-names>G</given-names>
</name>
<name>
<surname>Cevik</surname> 
<given-names>H</given-names>
</name>
<name>
<surname>Ersoy</surname> 
<given-names>Y</given-names>
</name>
<name>
<surname>Arbak</surname> 
<given-names>S</given-names>
</name>
<name>
<surname>Yegen</surname> 
<given-names>BC</given-names>
</name>
</person-group>
<article-title>Amelioration of methotrexate-induced enteritis by melatonin in rats</article-title>
<source>Cell Biochem Funct</source>
<year>2004</year>
<volume>22</volume>
<issue>3</issue>
<fpage>169</fpage>
<lpage>78</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0039">
<label>39</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sener</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ek&#x015F;ioglu-Demiralp</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cetiner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ercan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sirvanci</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gedik</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death</article-title>
<source>Cell Biol Toxicol.</source>
<year>2006</year>
<volume>22</volume>
<issue>1</issue>
<fpage>47</fpage>
<lpage>60</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0040">
<label>40</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kellum</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Kaldas</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells</article-title>
<source>J Pharmacol Exp Ther.</source>
<year>2004</year>
<volume>308</volume>
<issue>1</issue>
<fpage>307</fpage>
<lpage>16</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0041">
<label>41</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tawadrous</surname>
<given-names>ZS</given-names>
</name>
<name>
<surname>Delude</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Resuscitation from hemorrhagic shock with Ringer&#x0027;s ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats</article-title>
<source>Shock.</source>
<year>2002</year>
<volume>17</volume>
<issue>6</issue>
<fpage>473</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0042">
<label>42</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsung</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kaizu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bucher</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>MP</given-names>
</name>
<etal/>
</person-group>
<article-title>Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis</article-title>
<source>Transplantation.</source>
<year>2005</year>
<volume>79</volume>
<issue>2</issue>
<fpage>196</fpage>
<lpage>204</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0043">
<label>43</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vardi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Parlakpinar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cetin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Erdogan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cetin Ozturk</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Protective effect of beta-carotene on methotrexate-induced oxidative liver damage</article-title>
<source>Toxicol Pathol.</source>
<year>2010</year>
<volume>38</volume>
<issue>4</issue>
<fpage>592</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0044">
<label>44</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babiak</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Campello</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Carnieri</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>Methotrexate: pentose cycle and oxidative stress</article-title>
<source>Cell Biochem Funct.</source>
<year>1998</year>
<volume>16</volume>
<issue>4</issue>
<fpage>283</fpage>
<lpage>93</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0045">
<label>45</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabassum</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Raisuddin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Parvez</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice</article-title>
<source>Clin Chim Acta.</source>
<year>2006</year>
<volume>370</volume>
<issue>1-2</issue>
<fpage>129</fpage>
<lpage>36</lpage>
</nlm-citation>
</ref> 
<ref id="CIT0046">
<label>46</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ajami</surname> 
<given-names>AM</given-names>
</name>
<name>
<surname>Sims</surname> 
<given-names>CA</given-names>
</name>
<name>
<surname>Fink</surname> 
<given-names>MP</given-names>
</name>
<collab>investors</collab>
</person-group>
<article-title>Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion</article-title>
<source>United States patent US</source>
<year>2004</year>
<volume>10</volume>
<fpage>116</fpage>
<lpage>707</lpage>
</nlm-citation>
</ref></ref-list>
</back>
</article>